Ironjustic
Wed, Mar-12-08, 17:15
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the
antitumor activity of cannabidiol, a non-psychoactive
cannabinoid Authors: Massi, P.1; Valenti, M.2; Vaccani, A.2;
Gasperi, V.3; Perletti, G.2; Marras, E.2; Fezza, F.;
Maccarrone, M.; Parolaro, D.2
Source: Journal of Neurochemistry, Volume 104, Number 4,
February 2008 , pp. 1091-1100(10)
Publisher: Blackwell Publishing Abstract:
It has been recently reported that cannabidiol (CBD), a non-
psychoactive cannabinoid, is able to kill glioma cells, both
in vivo and in vitro, independently of cannabinoid receptor
stimulation. However, the underlying biochemical mechanisms
were not clarified. In the present study, we performed
biochemical analysis of the effect of CBD both in vivo, by
using glioma tumor tissues excised from nude mice, and in
vitro, by using U87 glioma cells. In vivo exposure of tumor
tissues to CBD significantly decreased the activity and
content of 5-lipoxygenase (LOX, by =E2=88=BC=E2=80=8940%),
and = of its end product leukotriene B4
(=E2=88=BC=E2=80=8925%). In contrast cyclooxygenase (COX)-2
activity and content, and the amount of its end product
prostaglandin E2, were not affected by CBD. In addition, in
vivo treatment with CBD markedly stimulated
(=E2=88=BC=E2=80=
=89175%)
the activity of fatty acid amide hydrolase (FAAH), the main
anandamide- degrading enzyme, while decreasing anandamide
content (=E2=88=BC=E2=80=8930%= ) and binding to CB1
cannabinoid receptors (=E2=88=BC=E2=80=8925%). In vitro pre-t=
reatment of U87 glioma cells with MK-886, a specific 5-LOX
inhibitor, significantly enhanced the antimitotic effect of
CBD, whereas the pre- treatment with indomethacin (pan-COX
inhibitor) or celecoxib (COX-2 inhibitor), did not alter CBD
effect. The study of the endocannabinoid system revealed that
CBD was able to induce a concentration-dependent increase of
FAAH activity in U87 cells. Moreover, a significantly reduced
growth rate was observed in FAAH-over-expressing U87 cells,
compared to wild-type controls. In conclusion, the present
investigation indicates that CBD exerts its antitumoral
effects through modulation of the LOX pathway and of the
endocannabinoid system, suggesting a possible interaction of
these routes in the control of tumor growth. Keywords:
cannabidiol; cyclooxygenase; endocannabinoid system; glioma;
lipoxygenase
Document Type: Research article
DOI: 10.1111/j.1471-4159.2007.05073.x
Affiliations: 1: Department of Pharmacology, Chemotherapy and
Toxicology, University of Milan, Milan, Italy 2: Department of
Structural and Functional Biology, Pharmacology Section,
Center of Neuroscience, University of Insubria, Busto Arsizio,
Italy 3: Department of Biomedical Sciences, University of
Teramo, Teramo, Italy
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING http://tinyurl.com/zk9fk
antitumor activity of cannabidiol, a non-psychoactive
cannabinoid Authors: Massi, P.1; Valenti, M.2; Vaccani, A.2;
Gasperi, V.3; Perletti, G.2; Marras, E.2; Fezza, F.;
Maccarrone, M.; Parolaro, D.2
Source: Journal of Neurochemistry, Volume 104, Number 4,
February 2008 , pp. 1091-1100(10)
Publisher: Blackwell Publishing Abstract:
It has been recently reported that cannabidiol (CBD), a non-
psychoactive cannabinoid, is able to kill glioma cells, both
in vivo and in vitro, independently of cannabinoid receptor
stimulation. However, the underlying biochemical mechanisms
were not clarified. In the present study, we performed
biochemical analysis of the effect of CBD both in vivo, by
using glioma tumor tissues excised from nude mice, and in
vitro, by using U87 glioma cells. In vivo exposure of tumor
tissues to CBD significantly decreased the activity and
content of 5-lipoxygenase (LOX, by =E2=88=BC=E2=80=8940%),
and = of its end product leukotriene B4
(=E2=88=BC=E2=80=8925%). In contrast cyclooxygenase (COX)-2
activity and content, and the amount of its end product
prostaglandin E2, were not affected by CBD. In addition, in
vivo treatment with CBD markedly stimulated
(=E2=88=BC=E2=80=
=89175%)
the activity of fatty acid amide hydrolase (FAAH), the main
anandamide- degrading enzyme, while decreasing anandamide
content (=E2=88=BC=E2=80=8930%= ) and binding to CB1
cannabinoid receptors (=E2=88=BC=E2=80=8925%). In vitro pre-t=
reatment of U87 glioma cells with MK-886, a specific 5-LOX
inhibitor, significantly enhanced the antimitotic effect of
CBD, whereas the pre- treatment with indomethacin (pan-COX
inhibitor) or celecoxib (COX-2 inhibitor), did not alter CBD
effect. The study of the endocannabinoid system revealed that
CBD was able to induce a concentration-dependent increase of
FAAH activity in U87 cells. Moreover, a significantly reduced
growth rate was observed in FAAH-over-expressing U87 cells,
compared to wild-type controls. In conclusion, the present
investigation indicates that CBD exerts its antitumoral
effects through modulation of the LOX pathway and of the
endocannabinoid system, suggesting a possible interaction of
these routes in the control of tumor growth. Keywords:
cannabidiol; cyclooxygenase; endocannabinoid system; glioma;
lipoxygenase
Document Type: Research article
DOI: 10.1111/j.1471-4159.2007.05073.x
Affiliations: 1: Department of Pharmacology, Chemotherapy and
Toxicology, University of Milan, Milan, Italy 2: Department of
Structural and Functional Biology, Pharmacology Section,
Center of Neuroscience, University of Insubria, Busto Arsizio,
Italy 3: Department of Biomedical Sciences, University of
Teramo, Teramo, Italy
Who loves ya. Tom
Jesus Was A Vegetarian! http://jesuswasavegetarian.7h.com
Man Is A Herbivore! http://tinyurl.com/a3cc3
DEAD PEOPLE WALKING http://tinyurl.com/zk9fk